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 Medicine is one of the most important part of the healing process, the 
restoration of health and prevention of disease. This study aims to describe 
the use of drugs, particularly antihypertensive and antiplatelet drugs in stroke 
patients hospitalized in PKU Muhammadiyah Hospital Bantul during 
December 2014-April 2015. This research is observational descriptive study. 
Data collection was done prospectively with a survey of stroke patients in 
inpatient Al-Insan and al-A'raaf wards  in PKU Muhammadiyah Hospital 
Bantul during the specified period. During the study there were 61 stroke 
patients sampled in the study, of which 41 (67.2%) were geriatrics and 20 
(32.8%) were not geriatrc. From the data, 28 (45.9%) patients did not receive 
antihypertensive drugs, only 33 (54,1%) patients received antihypertensive 
drug.The antihypertensive drugs type were given to patients were  ACEI 9 
(14.8%) and CCB 6 (9.8%), as well as combinations ACEI and CCB 7 
(11.5%). Most patients did not receive antiplatelet 43 (70.5%), whereas 
patients receiving antiplatelet drugs most was the kind of aspirin 17 (27.9%). 
From the above data it can be concluded that the use of antihypertensive 
drugs in stroke patients in the inpatient ward in PKU Muhamaddiyah 
Hospital Bantul quite frequently used, while the use of antiplatelet drugs in 
these cases rarely used. 
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1. INTRODUCTION 
Decision drug use always contains the consideration of benefits and risks. Patients who received the 
drug at risk of experiencing drug-related problems. The complexity of the disease and drug use, as well as 
highly individual patient response increasing emergence of drug-related problems [1].  
The goal of therapy with medication is the achievement of therapeutic outcome, namely improving 
the quality of life of patients with minimal risk. In each there is a risk of drug use, whether known or not, 
called drug misadventure, which included adverse drug reactions and medication errors. Adverse drug 
reactions are more affected by the condition of the patients, whereas medication errors occur due to human 
error or weakness of the existing system [2]. 
One of the diseases which is a medical emergency that can cause physical and mental disabilities, 
and can cause sudden death was a stroke. Stroke is a cerebrovascular disease is the leading cause of death is 
often the case in Indonesia. Service centers in neurology Indonesia number of people with circulatory 
disorders of the brain (GPDO) station is the first of all patient admissions [3], [4]. The prevalence of stroke in 
Indonesia amounted to 12.1 deaths per 1000 population and which has been diagnosed by health personnel 
IJPHS ISSN: 2252-8806  
 
The Use of Antihypertensive and Antiplatelet Drugs on Hospital Stroke Patients (Anggy Rima Putri) 
253 
was 7 deaths per 1000 population. Stroke causes of death in almost all hospitals in Indonesia, namely 14.5 
percent [5]. 
 
 
2. RESEARCH METHOD 
2.1. Research tool 
The tool used for research in the form of Case Record Form (CRF). 
 
2.2. Materials research 
Materials used in the study are primary data and secondary data. The primary data comes from 
interviews to patients while secondary data derived from the patient's medical record. Information obtained 
from both primary data and secondary data is then written in the Case Record Form (CRF), which has been 
created by researchers and has been in legitimate right by the ethics committee of the University of Ahmad 
Dahlan. 
 
2.3. Stage of Research 
2.3.1. Study design 
This is a descriptive observational research. Data were collected data collection was done 
prospectively with a survey of stroke patients in inpatient Al-Insan and al-A'raaf wards in PKU 
Muhammadiyah Hospital Bantul during the month of December 2014-April 2015.  
 
2.3.2. Sampling 
Sample in this study were all patients with stroke in RS PKU Muhammmadiyah Bantul in the study 
period ie during December 2014-April 2015 were willing to engage in research and included in the inclusion 
criteria. Researchers conducted a personal approach to the patient or the patient's family to explain the intent 
and purpose of the study and ask the patient to be willing to become respondents in this study. Before data 
collection, subject to the approval of the respondents informed consent form signed by the respondents as 
proof that the respondents willing to participate in research and understand the purpose of the study. 
 
2.3.3. Operational definitions 
1) Patients in this study were all patients diagnosed stroke with or without comorbidities, who are 
hospitalized in the wards Al-Insan and al-A'raaf at PKU Muhammadiyah Hospital in Bantul in December 
2014-April 2015, until the patient go home, situation improved, referenced, or die.  
2) Stroke in this study used a definition of Lionel (2008) [6], ie cerebrovascular disease (blood vessel of the 
brain), which is marked by the death of brain tissue (cerebral infarction) resulting from reduced blood 
flow and oxygen to the brain. No second stroke classification, are: 
a) Stroke Ischemic or non-hemorrhagic stroke caused by atherosclerosis or thrombus that has blocked a 
blood vessel to the brain.  
b) Haemorrhagic stroke is a stroke caused by a ruptured blood vessel or bleeding in the brain, so that 
normal blood flow is hampered and blood seeps into the region in the brain and damage. 
3) Drug Use in this study are drugs given to inpatients with respect to the stroke their suffered. 
 
 
3. RESULTS AND ANALYSIS 
3.1. General characteristics 
This study discusses the use of antihypertensive and antiplatelet drugs in stroke patients who are 
hospitalized at PKU Muhammadiyah Hospital in Bantul with a sample of 61 patients. General characteristics 
of patients by age, gender, education, employment, and payments are presented in Table 1. 
According to the Table 1 in mind that the majority of patients aged> 60 years were 41 (67.2%). A total of 34 
(55.7%) were women. The majority of patients was completed elementary school were 42 (68.9%). A total of 
36 (59.0%) work as farmers, employee, and labor. A total of 41 (67.2%) payment by 
BPJS/Jamkesmas/Jamkesda. 
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Table 1. General Characteristics of Patients in Inpatient Ward PKU Muhammadiyah Hospital in Bantul 
Characteristics Frequency Percentage 
Age > 60 years 41 67.20 
 < 60 years 20 32.80 
Sex Man 27 44.30 
 Woman 34 55.70 
Education Elementary 42 68.90 
 Junior 10 16.40 
 Senior 9 14.80 
Job No work 17 27.90 
 PNS 1 1.60 
 Entrepreneur 7 11.50 
 Farmers, Employee, Labor 36 59.00 
Payment Public / Governmental 12 19.70 
 BPJS Askes PNS 7 11.50 
 BPJS Jamkesmas/Jamkesda 41 67.20 
 BPJS Mandiri 1 1.60 
 
 
3.2. Clinical characteristics 
Clinical characteristics include the patient arrives at the hospital, the category of stroke, diagnosis 
status, action MSCT head, RPD Stroke, and smoking history are presented in Table 2. 
 
 
Table 2. Clinical Characteristics of Patients in inpatient ward PKU Muhammadiyah Hospital in Bantul 
Characteristics Frequency Percentage 
Arrived in  < 4 hours 33 54.10 
hospital wards > 4 hours 28 45.90 
Stroke category Non Hemorrhagic Stroke 21 34.40 
 Hemorrhagic Stroke 7 11.50 
 Unidentified Stroke 33 54.10 
MSCT head Yes 28 45.90 
 No 33 54.10 
RPD stroke Yes 12 19.70 
 No 49 80.30 
History of  Yes 3 4.90 
Smoking No 38 62.30 
 Former smoker 20 32.80 
 
 
According to the table 2 that more than half of the patients arrived at the hospital <4 hours by 33 
(54.1%). A total of 33 (54.1%) of stroke was not identified. A total of 33 (54.1%) did not do MSCT head. 
Most patients with no history of stroke by 49 (80.3%). A total of 38 (62.3%) patients not to smoke. 
 
3.3. Drug use 
Description of Drug Use in the inpatient ward PKU Muhammadiyah Hospital in Bantul are 
presented in Table 3. Based on Table 3 is known that all patients did not receive thrombolytic, however, all 
patients received a neuroprotective. Most patients get the drug neurotrophic 56 (91.8%). A total of 33 
(54.1%) patients received antihypertensive drugs. Most patients did not receive antiplatelet, only 17 (27.9%) 
patients receiving antiplatelet drugs. Whereas patients received hemostatic drugs as much as 9 (14.8%). 
 
 
Table 3. Drug Use in the inpatient ward PKU Muhammadiyah Hospital in Bantul 
No Drug use Frequency Percentage 
1 Thrombolytic Not use 61 100.00 
  Use 0 0 
2 Neuroprotective Not use 0 0 
  Use 61 100.00 
3 Neurotrophic Not use 5 8.20 
  Use 56 91.80 
4 Antihypertensive Not use 28 45.90 
  Use 33 54.10 
5 Antiplatelet Not use 44 72.10 
  Use 17 27.90 
6 Hemostatic Not use 52 85.20 
  Use 9 14.80 
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3.4. Use of antihypertensive drugs and antiplatelet 
Antihypertensive Drug Use and Antiplatelet in stroke patients in the inpatient ward PKU 
Muhammadiyah Hospital in Bantul are presented in the following Table 4. 
 
 
Table 4. Drug Use in the inpatient ward PKU Muhammadiyah Hospital in Bantul 
No Drug use Frequency Percentage 
1 Antihypertensive Not use 28 45.90 
  ACEI 9 14.80 
  ARB 3 4.90 
  CCB 6 9.80 
  ARB,CCB 5 8.20 
  ARB,BB,CCB 1 1.60 
  ACEI,CCB 7 11.50 
  ACEI, BB, Diuretic 1 1.60 
  ACEI,ARB 1 1.60 
5 Antiplatelet Not use 43 70.50 
  Aspirin 17 27.90 
  Cilostazole 1 1.60 
 
 
Based on table 4 is known that as many as 28 (45.9%) patients did not receive antihypertensive 
drugs, whereas most patients antihypertensive drugs given to patients is the type of ACEI 9 (14.8%) and 
CCB 6 (9.8%), as well as combinations ACEI and CCB 7 (11.5%). Most patients do not receive antiplatelet 
43 (70.5%), whereas patients receiving antiplatelet drugs aspirin most is the kind of 17 (27.9%). 
Hypertension in patients with ischemic stroke, there is evidence that blood pressure will rise 
generally occurs during ischemic stroke and can last several days. The increase in blood pressure (high-
normal blood pressure) is needed to maintain the blood flow of the brain after a stroke occurs and going 
down slowly by itself without treatment. However, the blood pressure is too high cannot be left, so the need 
for giving of antihypertensive in stroke patients with certain conditions. In ischemic stroke systolic blood 
pressure> 220 mmHg or diastolic blood pressure> 110 mmHg should be given antihypertensive drugs [7]-[9]. 
In a hemorrhagic stroke decreased blood pressure will reduce the risk of re-bleeding or bleeding that is 
continuous, but the area around the hematoma increased ischemic brain because auto regulation in this area 
has been lost. On this basis antihypertensive drugs are given if the systolic pressure> 180 mmHg or diastolic 
blood pressure> 100 mmHg [10]. According Mancia  (2010) advocated the reduction of blood pressure as 
early as possible in intracerebral hemorrhage with mean arterial blood pressure> 145 mmHg, to prevent 
rebleeding, reduction of intracranial pressure and brain edema [11]. 
Antiplatelet therapy aims to prevent a secondary stroke in ischemic stroke by preventing clot 
formation. Giving antiplatelet could as a single agent or in combination with consideration of the advantages 
and disadvantages according to the patient's condition [12]. In this study antiplatelet drugs most commonly 
used is aspirin, where aspirin is an antiplatelet first choice for preventing the occurrence of ischemic stroke. 
The use of aspirin can reduce death and disability caused by ischemic stroke. The International Stroke Trial 
(IST), explains that aspirin 300 mg per day can significantly reduce stroke recurrence [13]. In the acute 
treatment of ischemic stroke cerebral blood flow restoration to remove the blockage/clots and stop cellular 
damage associated with ischemic/hypoxic, is the first medical treatment that should be given to stroke 
patients. Giving antiplatelet (aspirin) is recommended for every acute ischemic stroke [14]. 
 
 
4. CONCLUSION 
The results of this study indicate that the use of antihypertensive drugs in stroke patients in the 
inpatient ward PKU Muhamaddiyah Hospital Bantul used often enough, but not so with the use of 
antiplatelet drugs which in this case is still rarely used. This is probably related to the risk of gastroenteritis, 
especially for geriatric patients, as well as the type of stroke suffered by the patient, where giving of 
antiplatelet recommended in treatment of ischemic stroke, but are contraindicated when given in hemorrhagic 
stroke because it can increase the risk of bleeding. However, giving of antiplatelet still recommended for any 
cases of acute ischemic stroke, especially if the benefits received is greater than the risk/harm that may be 
caused. 
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